China Pharma Reports Slightly Higher Q2 Profits, Expects To Launch Generic Version Of AstraZeneca's Crestor In 2010
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China Pharma Holdings, a generic drug provider in China, reported that its net income inched up by 6.2 percent to $4.3 million in the second quarter of 2009 compared with the same period of 2008